MedTrace Logo

Brain Biomarkers of Response to Treatment for Apraxia of Speech

NCT02046941 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2019-08-28

Study results available
· View outcomes & findings →

Summary

The study will use MRI brain imaging to identify brain changes associated in stroke patients after they receive speech-language treatment for their speech difficulties.

Conditions

Interventions

BEHAVIORAL

Speech Production Treatment

This treatment employs a response-contingent hierarchy made up of verbal modeling/repetition, graphic cueing, integral stimulation, and articulatory placement instruction.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Juliana V. Baldo, PhD · VA Northern California Health Care System, Mather, CA

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-01
Primary Completion
2018-01-08
Completion
2018-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02046941 on ClinicalTrials.gov